mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.4 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.4 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.4 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |